<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39317338</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Annals of medicine</Title><ISOAbbreviation>Ann Med</ISOAbbreviation></Journal><ArticleTitle>The risk factors for long term cardiovascular symptoms in patients after coronavirus disease 2019 infection.</ArticleTitle><Pagination><StartPage>2407065</StartPage><MedlinePgn>2407065</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2407065</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/07853890.2024.2407065</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Presently, numerous studies have demonstrated that long-term cardiovascular changes after Coronavirus Disease 2019(COVID-19) infection should be considered. The study was aimed to explore the risk factors for post COVID-19 long-term cardiovascular symptoms.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This retrospective observational cross-sectional study involved 204 COVID-19 patients who were admitted to Yantaishan Hospital from January 1, 2023 to January 31, 2023. Demographic and laboratory data were collected and compared between patients who experienced post COVID-19 long-term cardiovascular symptoms and those who did not. Logistic regression analysis was used to identify the risk factors associated with the occurrence of post COVID-19 long-term cardiovascular symptoms.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Fifty-two participants presented Post COVID-19 cardiovascular symptoms, while the remaining 152 individuals did not show any such symptoms including chest pain, chest tightness, shortness of breath, palpitations, dyspnea, exercise intolerance, and postural tachycardia syndrome. In comparison to the group without post COVID-19 long-term cardiovascular symptoms, the group with post COVID-19 long-term cardiovascular symptoms exhibited a significantly higher prevalence of anxiety and depression (25.0% vs. 4.6%, <i>p</i>&#x2009;=&#x2009;0.000), as well as significantly elevated C-reactive protein (42.3&#x2009;mg/L vs. 20.3&#x2009;mg/L, <i>p</i>&#x2009;=&#x2009;0.014) and D-dimer (0.3&#x2009;mg/L vs. 0.22&#x2009;mg/L, <i>p</i>&#x2009;=&#x2009;0.024). Anxiety and depression (odds ratio [OR]&#x2009;=&#x2009;6.403, 95% confidence interval [CI]:2.180-18.809, <i>p</i>&#x2009;=&#x2009;0.001), C-reactive protein (OR = 1.009, 95%CI:1.003-1.015, <i>p</i>&#x2009;=&#x2009;0.006), D-dimer (OR = 1.455, 95%CI:1.004-2.109, <i>p</i>&#x2009;=&#x2009;0.048), and LDL-C (OR = 1.780, 95%CI:1.043-3.040, <i>p</i>&#x2009;=&#x2009;0.035) were identified as independent risk factors for post COVID-19 long-term cardiovascular symptoms.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Anxiety and depression, C-reactive protein, D-dimer, and LDL-C levels are associated with the development of post COVID-19 long-term cardiovascular symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cardiovascular Medicine Department, Yantaishan Hospital, Yantai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Haofei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cardiovascular Medicine Department, Yantaishan Hospital, Yantai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Med</MedlineTA><NlmUniqueID>8906388</NlmUniqueID><ISSNLinking>0785-3890</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005338">Fibrin Fibrinogen Degradation Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C036309">fibrin fragment D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005338" MajorTopicYN="N">Fibrin Fibrinogen Degradation Products</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cardiovascular</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword></KeywordList><CoiStatement>The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>4</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>19</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39317338</ArticleId><ArticleId IdType="pmc">PMC11423522</ArticleId><ArticleId IdType="doi">10.1080/07853890.2024.2407065</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bourgonje AR, Abdulle AE, Timens W, et al. . Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol. 2020;251(3):228&#x2013;248. doi: 10.1002/path.5471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5471</ArticleId><ArticleId IdType="pmc">PMC7276767</ArticleId><ArticleId IdType="pubmed">32418199</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanne JP, Bai H, Bernheim A, et al. . COVID-19 imaging: what we know now and what remains unknown. Radiology. 2021;299(3):E262&#x2013;e79. doi: 10.1148/radiol.2021204522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021204522</ArticleId><ArticleId IdType="pmc">PMC7879709</ArticleId><ArticleId IdType="pubmed">33560192</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid A, Petrovic M, Akella K, et al. . Getting to the heart of the matter: myocardial injury, coagulopathy, and other potential cardiovascular implications of COVID-19. Int J Vasc Med. 2021;2021:6693895. doi: 10.1155/2021/6693895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6693895</ArticleId><ArticleId IdType="pmc">PMC8118745</ArticleId><ArticleId IdType="pubmed">34035963</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassen MCH, Skaarup KG, Lind JN, et al. . Recovery of cardiac function following COVID-19 - ECHOVID-19: a prospective longitudinal cohort study. Eur J Heart Fail. 2021;23(11):1903&#x2013;1912. doi: 10.1002/ejhf.2347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2347</ArticleId><ArticleId IdType="pmc">PMC8652600</ArticleId><ArticleId IdType="pubmed">34514713</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Wirtheim E, Vetter P, et al. . Long-term consequences of COVID-19: research needs. Lancet Infect Dis. 2020;20(10):1115&#x2013;1117. doi: 10.1016/S1473-3099(20)30701-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30701-5</ArticleId><ArticleId IdType="pmc">PMC7462626</ArticleId><ArticleId IdType="pubmed">32888409</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et al. . Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4(10):e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo S, Zayachkivska O, Hussain A, et al. . What is really &#x2018;Long COVID&#x2019;? Inflammopharmacology. 2023;31(2):551&#x2013;557. doi: 10.1007/s10787-023-01194-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-023-01194-0</ArticleId><ArticleId IdType="pmc">PMC10039447</ArticleId><ArticleId IdType="pubmed">36964860</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Sanchis-Gomar F, Henry BM.. COVID-19 and its long-term sequelae: what do we know in 2023? Pol Arch Intern Med. 2023;133:16402. doi: 10.20452/pamw.16402.</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.16402</ArticleId><ArticleId IdType="pubmed">36626183</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al. . Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, et al. . Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed MO, Banerjee A.. Long COVID and cardiovascular disease: a learning health system approach. Nat Rev Cardiol. 2022;19(5):287&#x2013;288. doi: 10.1038/s41569-022-00697-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-022-00697-7</ArticleId><ArticleId IdType="pmc">PMC8943785</ArticleId><ArticleId IdType="pubmed">35332308</ArticleId></ArticleIdList></Reference><Reference><Citation>Farshidfar F, Koleini N, Ardehali H.. Cardiovascular complications of COVID-19. JCI Insight. 2021;6(13):e148980. doi: 10.1172/jci.insight.148980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.148980</ArticleId><ArticleId IdType="pmc">PMC8410051</ArticleId><ArticleId IdType="pubmed">34061779</ArticleId></ArticleIdList></Reference><Reference><Citation>Gy&#xf6;ngy&#xf6;si M, Alcaide P, Asselbergs FW, et al. . Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases. Cardiovasc Res. 2023;119(2):336&#x2013;356. doi: 10.1093/cvr/cvac115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvac115</ArticleId><ArticleId IdType="pmc">PMC9384470</ArticleId><ArticleId IdType="pubmed">35875883</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ, Halim A, Halim M, et al. . Inflammatory and vascular biomarkers in post-COVID-19 syndrome: a systematic review and meta-analysis of over 20 biomarkers. Rev Med Virol. 2023;33(2):e2424.</Citation><ArticleIdList><ArticleId IdType="pubmed">36708022</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollias A, Kyriakoulis KG, Dimakakos E, et al. . Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol. 2020;189(5):846&#x2013;847. doi: 10.1111/bjh.16727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16727</ArticleId><ArticleId IdType="pmc">PMC7264537</ArticleId><ArticleId IdType="pubmed">32304577</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodelo JR, De la Rosa G, Valencia ML, et al. . D-dimer is a significant prognostic factor in patients with suspected infection and sepsis. Am J Emerg Med. 2012;30(9):1991&#x2013;1999. doi: 10.1016/j.ajem.2012.04.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2012.04.033</ArticleId><ArticleId IdType="pubmed">22795996</ArticleId></ArticleIdList></Reference><Reference><Citation>Simadibrata DM, Lubis AM.. D-dimer levels on admission and all-cause mortality risk in COVID-19 patients: a meta-analysis. Epidemiol Infect. 2020;148:e202. doi: 10.1017/S0950268820002022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268820002022</ArticleId><ArticleId IdType="pmc">PMC7487805</ArticleId><ArticleId IdType="pubmed">32892787</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. . Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834&#x2013;847. doi: 10.1002/ajh.25829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25829</ArticleId><ArticleId IdType="pmc">PMC7262337</ArticleId><ArticleId IdType="pubmed">32282949</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W-J, Ni Z-Y, Hu Y, et al. . Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Sluijs KM, Bakker EA, Schuijt TJ, et al. . Long-term cardiovascular health status and physical functioning of nonhospitalized patients with COVID-19 compared with non-COVID-19 controls. Am J Physiol Heart Circ Physiol. 2023;324(1):H47&#x2013;h56. doi: 10.1152/ajpheart.00335.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00335.2022</ArticleId><ArticleId IdType="pmc">PMC9870581</ArticleId><ArticleId IdType="pubmed">36459448</ArticleId></ArticleIdList></Reference><Reference><Citation>Xuereb R-A, Borg M, Vella K, et al. . Long COVID syndrome: a case-control study. Am J Med. 2023: S0002d-9343(23)00299-1. doi: 10.1016/j.amjmed.2023.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.04.022</ArticleId><ArticleId IdType="pmc">PMC10168190</ArticleId><ArticleId IdType="pubmed">37169323</ArticleId></ArticleIdList></Reference><Reference><Citation>Elseidy SA, Awad AK, Vorla M, et al. . Cardiovascular complications in the Post-Acute COVID-19 syndrome (PACS). Int J Cardiol Heart Vasc. 2022;40:101012. doi: 10.1016/j.ijcha.2022.101012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2022.101012</ArticleId><ArticleId IdType="pmc">PMC8958273</ArticleId><ArticleId IdType="pubmed">35355927</ArticleId></ArticleIdList></Reference><Reference><Citation>Maamar M, Artime A, Pariente E, et al. . Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study. Curr Med Res Opin. 2022;38(6):901&#x2013;909. doi: 10.1080/03007995.2022.2042991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2042991</ArticleId><ArticleId IdType="pmc">PMC8935459</ArticleId><ArticleId IdType="pubmed">35166141</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>